Published on: Jan 04, 2017 at Specialty Pharmacy Times

Experimental Gastric Cancer Drug Enters Early Trial

By : Specialty Pharmacy Times

Athenex and Eli Lilly and Company are conducting a phase 1b clinical trial for advanced gastric cancer on the combination of Oraxol plus Cyramza (ramucircumab, the VEGF receptor 2 antagonist). Oraxol is an oral version of the common chemo drug paclitaxel.

Read More
SHARE